BMN Blog

AUG 24
Tracking Instances and Impact of COVID-19 Among Pediatric Cancer Patients By Emily Johnston, M.D., MS & Julie Wolfson, M.D., MSHS in Clinical

A pediatric oncologist colleague of ours from Cornell Medical Center in New York posted a question to Facebook on March 23, 2020: How would the new COVID-19 pandemic impact the pediatric cancer population? We were asking ourselves the same question here at Children’s of Alabama. As social distancing and virtual meetings became the norm, we put our heads together – nearly 1,000 miles apart – to figure out how best to provide ongoing care for our oncology patients.

The result is the Pediatric COVID-19 Cancer Case (POCC) Report, a national registry of pediatric cancer patients diagnosed with COVID-19. It’s designed to better help our fellow clinicians provide vital care during an evolving pandemic.

Read More
 
JUN 04

Fifty percent of women will have a Urinary Tract Infection (UTI) in their lifetime. A portion of those women will identify sexual intercourse as a precursor to their symptoms. Typical UTI symptoms include painful urination, lower abdominal pain, urinary frequency, urinary urgency, foul-smelling urine, and blood in their urine (hematuria).

Read More
Tags:
 
SEP 15

September is National Childhood Cancer and Sickle Cell Awareness Month. This year’s observance comes as we continue to learn more about COVID-19 and its effects, and we are fortunate that our pediatric hematology-oncology patients have not been severely impacted. Two of our faculty members, Julie Wolfson, MD, MSHS and Emily Johnston, MD, MS are involved in a national research effort to collect information on pediatric cancer patients infected with the virus.

Read More
 
NOV 14

As the new division director of the Pediatric Hematology-Oncology and Blood Marrow Transplantation program in the University of Alabama at Birmingham (UAB) Department of Pediatrics and Children’s of Alabama, my top priority is to build a well-rounded program; a program that is not only strong in its clinical mission – to provide the best treatment possible for children with cancer and blood diseases – but one that also has a strong research base, which includes clinical, basic and translational research.

Read More
 
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: